Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections

Biological Chemistry

Volumn 392, Issue 10, 2011, Pages 837-847

  Ludwig, Stephan ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

anti viral drugs; influenza A virus; natural products; signal transduction; virus cell interaction

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; ACETYLSALICYLIC ACID; AMANTADINE; ANTIVIRUS AGENT; CYSTUS 052; DAS 181; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; FAVIPIRAVIR; FIBROBLAST GROWTH FACTOR 4; GERANIUM SANGUINEUM EXTRACT; HEAT SHOCK PROTEIN 90 INHIBITOR; I KAPPA B; L 735822; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; OSELTAMIVIR; PEPTIDE DERIVATIVE; PLANT EXTRACT; POLYPHENOL DERIVATIVE; PRODELPHININDIN B 23 O GALLATE; PROTEINASE INHIBITOR; RESVERATROL; RIMANTADINE; SIALIDASE INHIBITOR; THEAFLAVINE DIGALLATE; UNCLASSIFIED DRUG; ZANAMIVIR;

AEROSOL; ANTIVIRAL ACTIVITY; CLINICAL TRIAL (TOPIC); DRUG SENSITIVITY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; GERANIUM SANGUINEUM; HUMAN; INFLUENZA; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H5N1); INFLUENZA B; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS B; MEDICINAL PLANT; MIXED INFECTION; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; REVIEW; SEASONAL INFLUENZA; SIGNAL TRANSDUCTION; VIROGENESIS; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TRANSMISSION;

ANIMALS; ANTIVIRAL AGENTS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; SIGNAL TRANSDUCTION;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 80052755593     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2011.121     Document Type: Review

References (110)

1. Aoki, F.Y., Boivin, G., and Roberts, N. (2007). Infl uenza virus susceptibility and resistance to oseltamivir. Antivir. Ther. 12 , 603-616
2. Basu, D., Walkiewicz, M.P., Frieman, M., Baric, R.S., Auble, D.T., and Engel, D.A. (2009). Novel influenza virus NS1 antagonists block replication and restore innate immune function. J. Virol. 83 , 1881-1891
3. Belser, J.A., Lu, X., Szretter, K.J., Jin, X., Aschenbrenner, L.M., Lee, A., Hawley, S., Kim do, H., Malakhov, M.P., Yu, M., et al. (2007). DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. J. Infect. Dis. 196 , 1493-1499
4. Boettcher, E., Matrosovich, T., Beyerle, M., Klenk, H.D., Garten, W.,and Matrosovich, M. (2006). Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 80 , 9896-9898
5. Bouamama, H., Villard, J., Benharref, A., and Jana, M. (1999). Antibacterial and antifungal activities of cistus incanus and C. monspeliensis leaf extracts. Therapie 54 , 731-733
6. Bovin, N.V., Tuzikov, A.B., Chinarev, A.A., and Gambaryan, A.S. (2004). Multimeric glycotherapeutics: new paradigm. Glycoconj. J. 21 , 471-478
7. Brass, A.L., Huang, I.C., Benita, Y., John, S.P., Krishnan, M.N., Feeley, E.M., Ryan, B.J., Weyer, J.L., van der Weyden, L., Fikrig, E., et al. (2009). The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139 , 1243-1254
8. Bright, R.A., Shay, D.K., Shu, B., Cox, N.J., and Klimov, A.I. (2006). Adamantane resistance among influenza A viruses isolated early during the 2005 - 2006 influenza season in the United States. J. Am. Med. Assoc. 295 , 891-894
9. Brooks, M.J., Sasadeusz, J.J., and Tannock, G.A. (2004). Anti-viral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline? Curr. Opin. Pulm. Med. 10 , 197-203
10. Chase, G., Deng, T., Fodor, E., Leung, B.W., Mayer, D., Schwemmle,M., and Brownlee, G. (2008). Hsp90 inhibitors reduce influenza virus replication in cell culture. Virology 377 , 431-439
11. Cheng, H.Y., Lin, C.C., and Lin, T.C. (2002). Anti-viral properties of prodelphinidin β2 3′-O-gallate from green tea leaf. Antivir. Chem. Chemother. 13 , 223-229
12. Chu, W.M., Ostertag, D., Li, Z.W., Chang, L., Chen, Y., Hu, Y., Williams, B., Perrault, J., and Karin, M. (1999). JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11 , 721-731
13. Cohen, P. (2002). Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1 , 309-315
14. Conenello, G.M. and Palese, P. (2007). Infl uenza A virus PB1-F2:a small protein with a big punch. Cell Host Microbe. 2 , 207-209
15. Cos, P., De Bruyne, N., Hermans, S., Apers, S., Vanden Berghe, D., and Vlietinck, A.J. (2003a). Proanthocyanidins in health care: current and new trends. Curr. Med. Chem. 10 , 1345-1359
16. Cos, P., Vanden Berghe, D., and De Bruyne, N. (2003b). Plant substrates as anti-viral agents: an update (1997 - 2001). Curr. Org. Chem. 7 , 1163-1180
17. Crusat, M. and de Jong, M.D. (2007). Neuraminidase inhibitors and their role in avian and pandemic influenza. Antivir. Ther. 12 , 593-602
18. Danne, A., Petereit, F., and Nahrstedt, A. (1993). Proanthocyanidins from cistus incanus. Phytochemistry 14 , 1129-1133
19. De Clercq, E. and Neyts, J. (2007). Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention. Trends Pharmacol. Sci. 28 , 280-285
20. Droebner, K., Ehrhardt, C., Poetter, A., Ludwig, S., and Planz, O. (2007). CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral Res. 76 , 1-10
21. Droebner K., Pleschka S., Ludwig S., Planz O. (2011). Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. Antiviral Res. [Aug 11, Epub ahead of print] PMID: 21854809
22. Ehrhardt, C., Hrincius, E.R., Korte, V., Mazur, I., Droebner, K.,Poetter, A., Dreschers, S., Schmolke, M., Planz, O., and Ludwig, S. (2007). A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Antiviral Res. 76 , 38-47
23. Ehrhardt, C. and Ludwig, S. (2009). A new player in a deadly game:influenza viruses and the PI3K/Akt signalling pathway. Cell Microbiol 11, 863-871
24. Eisenberg, S., Shvartsman, D.E., Ehrlich, M., and Henis, Y.I. (2006). Clustering of raft-associated proteins in the external membrane leafl et modulates internal leafl et H-ras diffusion and signaling. Mol. Cell Biol. 26 , 7190-7200
25. Faleiro, L. and Lazebnik, Y. (2000). Caspases disrupt the nuclearcytoplasmic barrier. J. Cell Biol. 151 , 951-959
26. Furuta, Y., Takahashi, K., Fukuda, Y., Kuno, M., Kamiyama, T., Kozaki, K., Nomura, N., Egawa, H., Minami, S., Watanaße, Y., et al. (2002). In vitro and in vivo activities of anti-influenza virus compound T-705 Antimicrob. Agents Chemother. 46 , 977-981
27. Gack, M.U., Albrecht, R.A., Urano, T., Inn, K.S., Huang, I.C., Carnero, E., Farzan, M., Inoue, S., Jung, J.U., and Garcia-Sastre, A. (2009). Infl uenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5, 439-449
28. Garten, W., Bosch, F.X., Linder, D., Rott, R., and Klenk, H.D. (1981). Proteolytic activation of the influenza virus hemagglutinin: the structure of the cleavage site and the enzymes involved in cleavage. Virology 115 , 361-374
29. Ghanem, A., Mayer, D., Chase, G., Tegge, W., Frank, R., Kochs, G., Garcia-Sastre, A., and Schwemmle, M. (2007). Peptide-mediated interference with influenza A virus polymerase. J. Virol. 81 , 7801-7804
30. Gubareva, L.V., Kaiser, L., and Hayden, F.G. (2000). Infl uenza virus neuraminidase inhibitors. Lancet 355 , 827-835
31. Hai, R., Schmolke, M., Varga, Z.T., Manicassamy, B., Wang, T.T., Belser, J.A., Pearce, M.B., Garcia-Sastre, A., Tumpey, T.M., and Palese, P. (2010). PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J. Virol. 84 , 4442-4450
32. Hale, B.G., Randall, R.E., Ortin, J., and Jackson, D. (2008). The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89 , 2359-2376
33. Hao, L., Sakurai, A., Watanaße, T., Sorensen, E., Nidom, C.A., Newton, M.A., Ahlquist, P., and Kawaoka, Y. (2008). Drosophila RNAi screen identifi es host genes important for influenza virus replication. Nature 454 , 890-893
34. Harborne, J. (1980). Plant polyphenolics. In: Encyclopedia of Plant Physiology, E. Bell and B. Charlwood, eds. (Springer Verlag, Berlin Heidelberg, New York), pp. 329 - 395
35. Haslam, E. (1996). Natural polyphenols (VegetAβle Tannins) as drugs: possible modes of action. J. Nat. Prod. 59 , 205-215
36. Hayden, F. (2009). Developing new anti-viral agents for influenza treatment: what does the future hold ? Clin. Infect. Dis. 48 (Suppl 1) , S3-S3
37. Hayden, F.G. and Hay, A.J. (1992). Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr. Top Microbiol. Immunol. 176 , 119-130
38. Hedlund, M., Aschenbrenner, L.M., Jensen, K., Larson, J.L., and Fang, F. (2010). Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection. J. Infect. Dis. 201 , 1007-1015
39. Heikkinen, L.S., Kazlauskas, A., Melen, K., Wagner, R., Ziegler, T.,Julkunen, I., and Saksela, K. (2008). Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling. J. Biol. Chem. 283 , 5719-5727
40. Hrincius, E.R., Wixler, V., Wolff, T., Wagner, R., Ludwig, S., and Ehrhardt, C. (2010). CRK adaptor protein expression is required for effi cient replication of avian influenza A viruses and controls JNK-mediated apoptotic responses. Cell Microbiol. 12 , 831-843
41. Huang, Y.L., Loke, S.H., Hsu, C.C., and Chiou, W.F. (2008). (+)-Vitisin A inhibits influenza A virus-induced RANTES production in A549 alveolar epithelial cells through interference with Akt and STAT1 phosphorylation. Planta. Med. 74 , 156-162
42. Inn, K.S., Gack, M.U., Tokunaga, F., Shi, M., Wong, L.Y., Iwai, K., and Jung, J.U. (2011). Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. Mol. Cell 41 , 354-365
43. Jones, J.C., Turpin, E.A., Bultmann, H., Brandt, C.R., and Schultz-Cherry, S. (2006). Inhibition of influenza virus infection by a novel anti-viral peptide that targets viral attachment to cells. J. Virol. 80 , 11960-11967
44. Kalus, U., Grigorov, A., Kadecki, O., Jansen, J.P., Kiesewetter, H., and Radtke, H. (2009). Cistus incanus (CYSTUS052) for treating patients with infection of the upper respiratory tract. A prospective, randomised, placebo-controlled clinical study. Antiviral Res. 84 , 267-271
45. Kalus, U., Kiesewetter, H., and Radtke, H. (2010). Effect of CYSTUS052 and green tea on subjective symptoms in patients with infection of the upper respiratory tract. Phytother. Res. 24 , 96-100
46. Karlas, A., Machuy, N., Shin, Y., Pleissner, K.P., Artarini, A., Heuer,D., Becker, D., Khalil, H., Ogilvie, L.A., Hess, S., et al. (2010). Genome-wide RNAi screen identifi es human host factors crucial for influenza virus replication. Nature 463 , 818-822
47. Kiso, M., Mitamura, K., Sakai-Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F.G., Sugaya, N., and Kawaoka, Y. (2004). Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364 , 759-765
48. Konig, R., Stertz, S., Zhou, Y., Inoue, A., Hoffmann, H.H., Bhattacharyya, S., Alamares, J.G., Tscherne, D.M., Ortigoza, M.B., Liang, Y., et al. (2010). Human host factors required for influenza virus replication. Nature 463 , 813-817
49. Kramer, A., Liashkovich, I., Oberleithner, H., Ludwig, S., Mazur, I., and Shahin, V. (2008). Apoptosis leads to a degradation of vital components of active nuclear transport and a dissociation of the nuclear lamina. Proc. Natl. Acad. Sci. USA 105 , 11236-11241
50. Krawitz, C., Mraheil, M.A., Stein, M., Imirzalioglu, C., Domann, E., Pleschka, S., and Hain, T. (2011). Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement. Altern. Med. 11 , 16
51. Kubo, M., Hanada, T., and Yoshimura, A. (2003). Suppressors of cytokine signaling and immunity. Nat. Immunol. 4 , 1169-1176
52. Kumar, N., Xin, Z.T., Liang, Y., Ly, H., and Liang, Y. (2008). NF-kappAβ signaling differentially regulates influenza virus RNA synthesis. J. Virol. 82 , 9880-9889
53. Lackenby, A., Thompson, C.I., and Democratis, J. (2008). The potential impact of neuraminidase inhibitor resistant influenza. Curr. Opin. Infect. Dis. 21 , 626-638
54. Lau, J.T., Leung, P.C., Wong, E.L., Fong, C., Cheng, K.F., Zhang, S.C., Lam, C.W., Wong, V., Choy, K.M., and Ko, W.M. (2005). The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study. J. Altern. Complement. Med. 11 , 49-55
55. Ludwig, S. (2007a). Exploited defense - how influenza virus takes advantage of antivral signaling responses. Future Virology 2 , 91-100
56. Ludwig, S. (2007b). Infl uenza viruses and MAP kinase cascades - Novel targets for anti-viral therapy ? Signal Transduction 7 , 81-88
57. Ludwig, S. and Planz, O. (2008). Infl uenza viruses and the NF-kappAβ signaling pathway-towards a novel concept of anti-viral therapy. Biol. Chem. 389 , 1307-1312
58. Ludwig, S., Planz, O., Pleschka, S., and Wolff, T. (2003). Infl uenza virus induced signaling pathways - Targets for anti-viral therapy ? Trends Mol. Med. 9 , 46-51
59. Ludwig, S., Pleschka, S., Planz, O., and Wolff, T. (2006). Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell Microbiol. 8 , 375-386
60. Ludwig, S., Wolff, T., Ehrhardt, C., Wurzer, W.J., Reinhardt, J., Planz, O., and Pleschka, S. (2004). MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. FEBS Lett. 561 , 37-43
61. Maenz, B., Goetz, V., Wunderlich, K., Eisel, J., Kirchmair, J., Stech, J., Stech, O., Chase, G., Frank, R., and Schwemmle, M. (2011). Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza A virus. J. Biol. Chem. 286 , 8414-8424
62. Malakhov, M.P., Aschenbrenner, L.M., Smee, D.F., Wandersee, M.K., Sidwell, R.W., Gubareva, L.V., Mishin, V.P., Hayden, F.G., Kim, D.H., Ing, A., et al. (2006). Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob. Agents Chemother. 50 , 1470-1479
63. Manach, C., Scalbert, A., Morand, C., Remesy, C., and Jimenez, L. (2004). Polyphenols: food sources and bioavailAβility. Am. J. Clin. Nutr. 79 , 727-747
64. Marjuki, H., Alam, M.I., Ehrhardt, C., Wagner, R., Planz, O., Klenk, H.D., Ludwig, S., and Pleschka, S. (2006). Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Cα-mediated activation of ERK signaling. J. Biol. Chem. 281 , 16707-16715
65. Maroto, M., Fernandez, Y., Ortin, J., Pelaez, F., and Caßello, M.A. (2008). Development of an HTS assay for the search of antiinfluenza agents targeting the interaction of viral RNA with the NS1 protein. J. Biomol. Screen 13 , 581-590
66. Mazur, I., Anhlan, D., Mitzner, D., Wixler, L., Schubert, U., and Ludwig, S. (2008). The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol. 10 , 1140-1152
67. Mazur, I., Wurzer, W.J., Ehrhardt, C., Pleschka, S., Puthavathana, P., Silberzahn, T., Wolff, T., Planz, O., and Ludwig, S. (2007). Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappAβ-inhibiting activity. Cell Microbiol. 9 , 1683-1694
68. McAuley, J.L., Zhang, K., and McCullers, J.A. (2010). The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specifi c and do not impact pathogenesis. J Virol. 84 , 558-564
69. Murzakhmetova, M., Moldakarimov, S., Tancheva, L., Aßarova, S.,and Serkedjieva, J. (2008). Antioxidant and prooxidant properties of a polyphenol-rich extract from Geranium sanguineum L. in vitro and in vivo. Phytother. Res. 22 , 746-751
70. Nakayama, M., Suzuki, K., Toda, M., Okubo, S., Hara, Y., and Shimamura, T. (1993). Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res. 21 , 289-299
71. Nichol, K.L., Lind, A., Margolis, K.L., Murdoch, M., McFadden, R., Hauge, M., Magnan, S., and Drake, M. (1995). The effectiveness of vaccination against influenza in healthy, working adults. N. Engl. J. Med. 333 , 889-893
72. Nimmerjahn, F., Dudziak, D., Dirmeier, U., Hobom, G., Riedel, A., Schlee, M., Staudt, L.M., Rosenwald, A., Behrends, U., Bornkamm, G.W., et al. (2004). Active NF-kappAβ signaling is a prerequisite for influenza virus infection. J. Gen. Virol. 85 , 2347-2356
73. Olschlager, V., Pleschka, S., Fischer, T., Rziha, H.J., Wurzer, W., Stitz,L., Rapp, U.R., Ludwig, S., and Planz, O. (2004). Lung-specifi c expression of active Raf kinase results in increased mortality of influenza A virus-infected mice. Oncogene 23 , 6639-6646
74. Oxford, J.S., Lambkin, R., Guralnik, M., Rosenbloom, R.A., Petteruti, M.P., Digian, K., and LeFante, C. (2007a). In vivo prophylactic activity of QR-435 against H3N2 influenza virus infection. Am.J. Ther. 14 , 462-468
75. Oxford, J.S., Lambkin, R., Guralnik, M., Rosenbloom, R.A., Petteruti, M.P., Digian, K., and Lefante, C. (2007b). Preclinical in vitro activity of QR-435 against influenza A virus as a virucide and in paper masks for prevention of viral transmission. Am. J. Ther. 14 , 455-461
76. Oxford, J.S., Novelli, P., Sefton, A., and Lambkin, R. (2002). New millennium anti-virals against pandemic and epidemic influenza: the neuraminidase inhibitors. Antivir. Chem. Chemother. 13 , 205-217
77. Pahl, H.L. (1999). Activators and target genes of Rel/NF-kappAβ transcription factors. Oncogene 18 , 6853-6866
78. Palamara, A.T., Nencioni, L., Aquilano, K., De Chiara, G., Hernandez, L., Cozzolino, F., Ciriolo, M.R., and Garaci, E. (2005). Inhibition of influenza A virus replication by resveratrol. J. Infect. Dis. 191 , 1719-1729
79. Pauli, E.K., Schmolke, M., Wolff, T., Viemann, D., Roth, J., Bode, J.G., and Ludwig, S. (2008). Infl uenza A virus inhibits type I IFN signaling via NF-kappAβ-dependent induction of SOCS-3 expression. PLoS Pathog. 4 , e1000196
80. Peiris, M. (2006). Pathogenesis of avian fl u H5N1 and SARS. Novartis Found Symp. 279 , 56 - 60; discussion 60 - 55, 216-219
81. Petereit, F., Kolodziej, H., and Nahrstedt, A. (1991). Flavons-3-ols and proanthocyanidins from Cistus incanus. Phytochemistry 30 , 981-985
82. Pinto, L.H. and Lamb, R.A. (2006). The M2 proton channels of influenza A and B viruses. J. Biol. Chem. 281 , 8997-9000
83. Pinto, L.H. and Lamb, R.A. (2007). Controlling influenza virus replication by inhibiting its proton channel. Mol. Biosyst. 3 , 18-23
84. Pinto, R., Herold, S., Cakarova, L., Hoegner, K., Lohmeyer, J., Planz, O., and Pleschka, S. (2011). Inhibition of influenza virusinduced NF-kappAβ and Raf-MEK-ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo. Antiviral Res. [May 27, Epub ahead of print] PMID: 2164193
85. Planz, O., Pleschka, S., and Ludwig, S. (2001). MEK-specifi c inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J. Virol. 75 , 4871-4877
86. Pleschka, S., Wolff, T., Ehrhardt, C., Hobom, G., Planz, O., Rapp, U. R., and Ludwig, S. (2001). Infl uenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 3 , 301-305
87. Scalbert, A. (1991). Antimicrobial properties of tannins. Phytochemistry 30 , 3875-3883
88. Schmolke, M., Viemann, D., Roth, J., and Ludwig, S. (2009). Essential impact of NF-kappAβ signaling on the H5N1 influenza A virus-induced transcriptome. J. Immunol . 183 , 5180-5189
89. Sebolt-Leopold, J.S., Dudley, D.T., Herrera, R., Van Becelaere, K., Wiland, A., Gowan, R.C., Tecle, H., Barrett, S.D., Bridges, A., Przybranowski, S., et al. (1999). Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5 , 810-816
90. Serkedjieva, J. (1997). Antiinfective activity of a plant preparation from Geranium sanguineum L. Pharmazie 52 , 799-802
91. Serkedjieva, J., Gegova, G., and Mladenov, K. (2008). Protective effi cacy of an aerosol preparation, obtained from Geranium sanguineum L., in experimental influenza infection. Pharmazie 63 , 160-163
92. Shapira, S.D., Gat-Viks, I., Shum, B.O., Dricot, A., de Grace, M.M., Wu, L., Gupta, P.B., Hao, T., Silver, S.J., Root, D.E., et al. (2009). A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139 , 1255-1267
93. Shaw, P. (2007). Orthomyxoviridae: the viruses and their replication. In: Fields: Virology, D.M. Knipe and P.M. Howley, eds. (Philadelphia: Lippencott Willams and Willams), pp. 1647 - 1689
94. Song, J.M., Lee, K.H., and Seong, B.L. (2005). Anti-viral effect of catechins in green tea on influenza virus. Antiviral Res. 68 , 66-74
95. Taguri, T., Tanaka, T., and Kouno, I. (2006). Antibacterial spectrum of plant polyphenols and extracts depending upon hydroxyphenyl structure. Biol. Pharm. Bull. 29 , 2226-2235
96. Thorlund, K., Awad, T., Boivin, G., and Thaßane, L. (2011). Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect. Dis. 11 , 134
97. Thornberry, N.A. and Lazebnik, Y. (1998). Caspases: enemies within.Science 281 , 1312-1316
98. Tomassini, J.E., Davies, M.E., Hastings, J.C., Lingham, R., Mojena, M., Raghoobar, S.L., Singh, S.B., Tkacz, J.S., and Goetz, M.A. (1996). A novel anti-viral agent which inhibits the endonuclease of influenza viruses. Antimicrob. Agents Chemother. 40 , 1189-1193
99. Twu, K.Y., Noah, D.L., Rao, P., Kuo, R.L., and Krug, R.M. (2006). The CPSF30 binding site on the NS1A protein of influenza A virus is a potential anti-viral target. J. Virol. 80 , 3957-3965
100. Varga, Z.T., Ramos, I., Hai, R., Schmolke, M., Garcia-Sastre, A., Fernandez-Sesma, A., and Palese, P. (2011). The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog. 7 , e1002067
101. Viemann, D., Schmolke, M., Lueken, A., Boergeling, Y., Friesenhagen, J., Wittkowski, H., Ludwig, S., and Roth, J. (2011). H5N1 virus activates signaling pathways in human endothelial cells resulting in a specifi c imbalanced infl ammatory response. J. Immunol. 186 , 164-173
102. Walkiewicz, M.P., Basu, D., Jaßlonski, J.J., Geysen, H.M., and Engel, D.A. (2011). Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner. J. Gen. Virol. 92 , 60-70
103. Widmann, C., Gibson, S., Jarpe, M.B., and Johnson, G.L. (1999). Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79 , 143-180
104. Wright, P.F., Neumann, G., and Kawaoka, Y. (2007). Orthomyxoviruses. In: Fields: Virology, D.M. Knipe and P.M. Howley, eds. (Philadelphia: Lippencott Willams and Willams), pp. 1691 - 1740
105. Wunderlich, K., Mayer, D., Ranadheera, C., Holler, A.S., Manz, B., Martin, A., Chase, G., Tegge, W., Frank, R., Kessler, U., et al. (2009). Identifi cation of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. PLoS One 4 , e7517
106. Wurzer, W.J., Ehrhardt, C., Pleschka, S., Berberich-Siebelt, F., Wolff, T., Walczak, H., Planz, O., and Ludwig, S. (2004) . NF-kappAβdependent induction of tumor necrosis factor-related apoptosisinducing ligand (TRAIL) and Fas/FasL is crucial for effi cient influenza virus propagation. J. Biol. Chem. 279 , 30931-30937
107. Wurzer, W.J., Planz, O., Ehrhardt, C., Giner, M., Silberzahn, T., Pleschka, S., and Ludwig, S. (2003). Caspase 3 activation is essential for effi cient influenza virus propagation. EMBO J. 22 , 2717-2728
108. Yin, M.J., Yamamoto, Y., and Gaynor, R.B. (1998). The antiinfl ammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396 , 77-80
109. Zamarin, D., Garcia-Sastre, A., Xiao, X., Wang, R., and Palese, P. (2005). Infl uenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1 PLoS Pathog. 1 , e4
110. Zhirnov, O.P., Ovcharenko, A.V., Bukrinskaia, A.G., Ursaki, L.P., and Ivanova, L.A. (1984). Anti-viral and therapeutic action of protease inhibitors in viral infections: experimental and clinical observations. Vopr. Virusol. 29 , 491-497